Reuters Health News Features OAPol Analysis

  • February 23, 2018

An OAPol analysis published last month in Arthritis Care & Research examined the loss of quality-adjusted life years among racial minorities due to disparities in total knee replacement utilization. Click here for coverage by Reuters Health.

Launch of the TeMPO Trial

  • February 2, 2018

ECL: First, can you give us an overview of the TeMPO trial in your own words? Why are we conducting this study? What do we want to know? JS: TeMPO is a randomized controlled trial of treatments for degenerative meniscal tear among adults who also have mild-to-moderate knee osteoarthritis. All the treatments are non-operative, including strengthening exercises and physical therapy…